Back
Celldex Therapeutics Vs. Avidity Biosciences Industry Stock Comparison
Sell
31
CLDX
Celldex Therapeutics
Last Price:
27.01
Seasonality Move:
17.85%
Sell
42
RNA
Avidity Biosciences
Last Price:
46.75
Seasonality Move:
39.98%
Sell
31
Celldex Therapeutics (CLDX)
is a Sell
Is Celldex Therapeutics a Buy, Sell or Hold?
- The current Celldex Therapeutics [CLDX] share price is $26.21. The Score for CLDX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- CLDX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $47.13. The Score for RNA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CLDX Stock Price Chart
What is Celldex Therapeutics's stock price today?
-
The Celldex Therapeutics share price today is $26.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLDX is experiencing slight buying pressure.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $47.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing slight selling pressure.
CLDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.83 | Sell |
| Relative Strength Index (14 RSI): | 36.83 | Sell |
| Chaikin Money Flow: | 30317 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.28 - 29.82) | Sell |
| Bollinger Bands (100): | (29.91 - 40.45) | Sell |
RNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 55.24 | Buy |
| Chaikin Money Flow: | -248351 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.93 - 47.71) | Buy |
| Bollinger Bands (100): | (41.2 - 46.58) | Buy |
CLDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.14 | Buy |
| 20-day SMA: | 27.46 | Sell |
| 50-day SMA: | 33.55 | Sell |
| 200-day SMA: | 37.35 | Sell |
| 8-day EMA: | 26.45 | Sell |
| 20-day EMA: | 27.79 | Sell |
| 50-day EMA: | 31.2 | Sell |
| 200-day EMA: | 35.18 | Sell |
RNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.33 | Buy |
| 20-day SMA: | 45.94 | Buy |
| 50-day SMA: | 44.62 | Buy |
| 200-day SMA: | 33.49 | Buy |
| 8-day EMA: | 46.11 | Buy |
| 20-day EMA: | 45.68 | Buy |
| 50-day EMA: | 44.8 | Buy |
| 200-day EMA: | 35.08 | Buy |
Celldex Therapeutics Earnings Growth & CLDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and a decrease next year of $0.84 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.36 per share.
Celldex Therapeutics Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avidity Biosciences Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||